Literature DB >> 7689034

Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma.

R Casalone1, P Portentoso, P Granata, E Minelli, R Righi, E Meroni, E Pozzi, A M Chiaravalli.   

Abstract

Cytogenetic studies of benign prostatic hyperplasia (BHP) are scarce. We analyzed primary cell cultures obtained from biopsies of prostatic tissues from 10 patients (mean age: 60.7 years) with histologic diagnosis of BHP to compare the eventual chromosome changes with those reported in prostatic adenocarcinoma. Clonal chromosome abnormalities were noted in five of the 10 cases, with loss of Y chromosome in all. In one case, a clonal t(1;20) was observed with a -Y clone. Different numerical and structural sporadic abnormalities were evident in eight. Chromosome 1 was the chromosome most frequently involved in sporadic rearrangements. We concluded that -Y is a frequent nonrandom chromosome abnormality in BHP in this sample of patients. Immunohistochemical studies showed that loss of Y occurs in fibroblasts and not in epithelial cells; therefore, this anomaly is not related to cancer development.

Entities:  

Mesh:

Year:  1993        PMID: 7689034     DOI: 10.1016/0165-4608(93)90008-a

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.

Authors:  T Visakorpi; E Hyytinen; A Kallioniemi; J Isola; O P Kallioniemi
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

2.  Chromosomal aberrations in benign prostatic hyperplasia patients.

Authors:  Muammer Altok; Özkan Bağcı; Mehmet Umul; Mustafa Güneş; Mehmet Akyüz; Fatih Uruç; Efkan Uz; Sedat Soyupek
Journal:  Investig Clin Urol       Date:  2016-01-11

3.  Genetic alterations in benign prostatic hyperplasia patients.

Authors:  Hanaa Mahmoud Mohamed; Magdy Sayed Aly; Tarek Dardeer Hussein
Journal:  Ger Med Sci       Date:  2017-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.